BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 36166194)

  • 1. ELEVATED PD-1/CD28 RATIO RATHER THAN PD-1 EXPRESSION IN CD8+ T CELLS PREDICTS NOSOCOMIAL INFECTION IN SEPSIS PATIENTS: A PROSPECTIVE, OBSERVATIONAL COHORT STUDY.
    Zhong W; Li J; Li D; Li X; Liu M; Zhang T; Huang J; Huang G; Zeng H; Zhou M; Jiang W
    Shock; 2022 Aug; 58(2):111-118. PubMed ID: 36166194
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased percentage of PD-L1
    Jiang W; Li X; Wen M; Liu X; Wang K; Wang Q; Li Y; Zhou M; Liu M; Hu B; Zeng H
    Crit Care; 2020 Oct; 24(1):617. PubMed ID: 33076951
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of dendritic cells on immune function regulated by programmed cell death-1/programmed cell death-ligand 1 in sepsis].
    Wang Z; Xie Z; Zhao Y; Bu T; Yu A; Wang S
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2021 Sep; 33(9):1032-1039. PubMed ID: 34839857
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PD-1 Expression on CD8+CD28- T cells within inflammatory synovium is associated with Relapse: A cohort of Rheumatoid Arthritis.
    Ajam F; Aghaei M; Mohammadi S; Samiei H; Behnampour N; Memarian A
    Immunol Lett; 2020 Dec; 228():76-82. PubMed ID: 33069765
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peripheral CD8+CD28+ T lymphocytes predict the efficacy and safety of PD-1/PD-L1 inhibitors in cancer patients.
    Geng R; Tang H; You T; Xu X; Li S; Li Z; Liu Y; Qiu W; Zhou N; Li N; Ge Y; Guo F; Sun Y; Wang Y; Li T; Bai C
    Front Immunol; 2023; 14():1125876. PubMed ID: 36969245
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating CD8
    Song Q; Ren J; Zhou X; Wang X; Song G; Hobeika A; Yuan Y; Lyerly HK
    Cytotherapy; 2018 Jan; 20(1):126-133. PubMed ID: 28988693
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PD-1 in Tregs predicts the survival in sepsis patients using sepsis-3 criteria: A prospective, two-stage study.
    Jiang W; Li X; Ding H; Wang K; Liu X; Wang Q; Li Y; Zhou M; Chen S; Zhong W; Li X; Zeng H
    Int Immunopharmacol; 2020 Dec; 89(Pt A):107175. PubMed ID: 33223466
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Expression of Programmed Death-1 on CD4+ and CD8+ T Lymphocytes in Patients with Type 2 Diabetes and Severe Sepsis.
    Jia Y; Zhao Y; Li C; Shao R
    PLoS One; 2016; 11(7):e0159383. PubMed ID: 27459386
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Diagnostic and prognostic value of peripheral lymphocyte subtyping for invasive candidiasis infection in critically ill patients with non-neutropenic sepsis].
    Han W; Wang H; Cui N; Zhang JH; Bai GX; Chen JW; Long Y
    Zhonghua Nei Ke Za Zhi; 2020 Dec; 59(12):968-975. PubMed ID: 33256338
    [No Abstract]   [Full Text] [Related]  

  • 10. Monocyte programmed death ligand-1 expression after 3-4 days of sepsis is associated with risk stratification and mortality in septic patients: a prospective cohort study.
    Shao R; Fang Y; Yu H; Zhao L; Jiang Z; Li CS
    Crit Care; 2016 May; 20(1):124. PubMed ID: 27156867
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic significance of peripheral CD8+CD28+ and CD8+CD28- T cells in advanced non-small cell lung cancer patients treated with chemo(radio)therapy.
    Liu C; Jing W; An N; Li A; Yan W; Zhu H; Yu J
    J Transl Med; 2019 Oct; 17(1):344. PubMed ID: 31623615
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The prognostic role of the programmed death-1 expression on T lymphocytes in septic patients].
    Xu C; Li L; Zhen JH; Zhou J; Gong SJ; Cai GL; Yan J
    Zhonghua Nei Ke Za Zhi; 2020 Oct; 59(10):796-800. PubMed ID: 32987482
    [No Abstract]   [Full Text] [Related]  

  • 13. Expression of PD-1 on Memory T Lymphocytes Predicts 28-Day Mortality of Patients with Sepsis: A Prospective Observational Study.
    Liu Q; Xue M; Song Q; Xie J; Yang Y; Liu S
    J Inflamm Res; 2022; 15():5043-5052. PubMed ID: 36072779
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early Expression of Functional Markers on CD4
    Chen J; Wang H; Guo R; Li H; Cui N
    Front Immunol; 2022; 13():938538. PubMed ID: 35898496
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PD-1 blockade-unresponsive human tumor-infiltrating CD8
    Kim KH; Kim HK; Kim HD; Kim CG; Lee H; Han JW; Choi SJ; Jeong S; Jeon M; Kim H; Koh J; Ku BM; Park SH; Ahn MJ; Shin EC
    Cell Mol Immunol; 2021 Feb; 18(2):385-397. PubMed ID: 32332901
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of the role of negative T cell costimulatory pathways in CD4 and CD8 T cell-mediated alloimmune responses in vivo.
    Ito T; Ueno T; Clarkson MR; Yuan X; Jurewicz MM; Yagita H; Azuma M; Sharpe AH; Auchincloss H; Sayegh MH; Najafian N
    J Immunol; 2005 Jun; 174(11):6648-56. PubMed ID: 15905503
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Analysis of death risk factors for nosocomial infection patients in an ICU: a retrospective review of 864 patients from 2009 to 2015].
    Wang J; Gao P; Guo S; Liu Y; Shao L; Kang H; Zhang J; Liu S; Gao X; Cui Z
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2016 Aug; 28(8):704-8. PubMed ID: 27434560
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of IL-10-secreting CD8
    Wang W; Tong Z; Zhong J; Zhang L; Zhang H; Su Y; Gao B; Zhang C
    Immunol Lett; 2018 Oct; 202():16-22. PubMed ID: 30055200
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lymphocyte expression of EZH2 is associated with mortality and secondary infectious complications in sepsis.
    Zhao D; Li Z; Liu X; Liu N; Bao X; Sun H; Meng Q; Ren H; Bai J; Zhou X; Tang L
    Int Immunopharmacol; 2020 Dec; 89(Pt B):107042. PubMed ID: 33068867
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A radiomics approach to assess tumour-infiltrating CD8 cells and response to anti-PD-1 or anti-PD-L1 immunotherapy: an imaging biomarker, retrospective multicohort study.
    Sun R; Limkin EJ; Vakalopoulou M; Dercle L; Champiat S; Han SR; Verlingue L; Brandao D; Lancia A; Ammari S; Hollebecque A; Scoazec JY; Marabelle A; Massard C; Soria JC; Robert C; Paragios N; Deutsch E; Ferté C
    Lancet Oncol; 2018 Sep; 19(9):1180-1191. PubMed ID: 30120041
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.